538 Substance-Related and Addictive Disorders
Comorbidity
Individuals with inhalant use disorder receiv ing clinical care often have numerous other
substance use disorders. Inhalant use disord er commonly co-occurs with adolescent con-
duct disorder and adult antisocial personality disorder. Adult inhalant use and inhalant
use disorder also are strongly associated wi th suicidal ideation and suicide attempts.
Inhalant Intoxication
Diagnostic Criteria
A. Recent intended or unintended short-term, high-dose exposure to inhalant sub-
stances, including volatile hydrocarbons such as toluene or gasoline.
B. Clinically significant problematic behavioral or psychological changes (e.g., belliger-
ence, assaultiveness, apathy, impaired judgment ) that developed during, or shortly af-
ter, exposure to inhalants.
C. Two (or more) of the following signs or symptoms developing during, or shortly after,
inhalant use or exposure:
1. Dizziness.
2. Nystagmus.
3. Incoordination.
4. Slurred speech.
5. Unsteady gait.
6. Lethargy.
7. Depressed reflexes.
8. Psychomotor retardation.
9. Tremor.
10. Generalized muscle weakness.
11. Blurred vision or diplopia.
12. Stupor or coma.
13. Euphoria.
D. The signs or symptoms are not attributable to another medical condition and are not bet-
ter explained by another mental disorder, including intoxication with another substance.
Coding note:  The ICD-9-CM code is 292.89.  The ICD-10-CM code depends on whether
there is a comorbid inhalant use disorder. If a mild inhalant use disorder is comorbid, the